Beclometasone Dipropionate/Formoterol pMDI

· Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Beclometasone Dipropionate/Formoterol pMDI, covering 2021-10-29 to 2021-10-29. Get the full timeline:

Most recent: Clinical Trial Update: Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI) [Phase 2]

See pricing